Tadora: Uses, Dosage & Safety Information

Tadora

Tadora

Tadora

Tadalafil
Tadora is an unapproved tadalafil product whose named manufacturer ceased to exist in 2003, so no current company stands behind it. Approved tadalafil carries a traceable manufacturer, NDC and FDA-reviewed labelling, and tadalafil must never be combined with nitrates or riociguat.
  • ActiveIngredient: Tadalafil
  • DosageForm: Oral tablet
  • Dosage: 10 mg, 20 mg, 40 mg
  • Indications: Erectile dysfunction
  • Storage: Store below 30°C
  • Drug Status: Not Approved

What is Tadora?

The company named as this brand’s manufacturer stopped existing in 2003. German Remedies was acquired by Zydus Cadila in 2001 and merged into Cadila Healthcare two years later; the name survives as a trademark. Sellers variously attribute Tadora to that dissolved firm, to its acquirer, or to Ajanta Pharma — an unrelated competitor.

The company named as manufacturer stopped existing in 2003
Vendor listings give the maker as German Remedies Private Ltd. That company was acquired by Zydus Cadila in 2001 and merged into Cadila Healthcare in 2003 by order of the Mumbai High Court.
German Remedies survives as a registered trademark and an internal business unit of Cadila Healthcare, not as a manufacturing entity that anyone could write to, complain to, or trace a batch through.

No product under this name appears in FDA labelling, Drugs@FDA, the drug registry or the adverse event database.3

The sources do not even agree with each other. Some listings name German Remedies, others name Zydus Cadila, and at least one names Ajanta Pharma — an unrelated company with its own competing tadalafil brands.

Listed under erectile dysfunction. What an identifiable tadalafil product records about itself is shown under Cialis and its registration details.

How to Take Tadora

A maker that no longer exists

The company named on this product ceased to exist in 2003, when it became part of another group, so nobody stands behind the name printed on the pack.

How approved tadalafil is taken

Approved tadalafil for erectile dysfunction is taken as needed, usually 10 mg before sexual activity and adjustable to 5 or 20 mg, or once daily at 2.5 or 5 mg; it can be taken with or without food.4

Checking a pack before use

An approved tadalafil pack names a manufacturer that exists today, a US National Drug Code and an expiry date; the pharmacist can confirm all three.

What not to do

Do not take tadalafil in any form with nitrates or riociguat, and do not take more than one dose in a day. Tell any emergency team that you have taken tadalafil, because its effect lasts up to 36 hours.4

What Are the Side Effects of Tadora?

No reports name this product in the FDA database, and no profile can be attached to a product whose maker cannot be identified.

Effects of the Molecule
QuestionAnswered by tadalafilAnswered by this product
Which effects occurHeadache, back pain, dyspepsia, nasal congestion, flushing—
At what doseEstablished across 2.5–20 mgStrength not registered
Made under what controlsInspected manufacturing for approved productsMaker not identifiable
Traceable to a batchYes, through product codesNo

Source: 43

The documented effects of tadalafil are on the a manufacturer that can be identified page, where they rest on trial data in a known product.

Emergency – seek care
  • Chest pain — and say you have taken tadalafil, whatever the packaging called it
  • An erection lasting more than four hours
  • Sudden loss of vision or hearing
  • Fainting or severe dizziness

What is Tadora Used For?

No approved use. The instructive material here is what happens when you try to find out who made a tablet.23

Three answers to one question

Manufacturer Attributions Across
Named as manufacturerStatus of that entity
German Remedies Private LtdMerged into Cadila Healthcare in 2003; survives as a trademark and business unit
Zydus CadilaThe successor company — consistent with the above, and the more accurate answer
Ajanta Pharma USA IncAn unrelated company that markets its own competing tadalafil brands

Source: 21

Packaging descriptions disagree too: some listings state four tablets per strip, others ten. Strengths of 10, 20 and twice the approved maximum appear across the range.2

Why the identity of the maker is a clinical question

It decides what you can do when something goes wrong. A named, existing manufacturer can be asked what is in a batch, can issue a recall, and can be held to an inspection regime. A trademark retired into another company’s catalogue two decades ago can do none of those things.

The disagreement itself is the finding. Where vendors cannot agree which company made a product — and one of their answers is a competitor — no user is in a position to verify anything about it.

Interactions Alcohol:

Unsafe
Both alcohol and tadalafil lower blood pressure, and neither the strength nor the maker of this product is established.

Interactions Other Medications:

Unsafe
Organic nitrates and guanylate cyclase stimulators are absolute contraindications with tadalafil. The alpha-blocker and CYP3A4 rules are dose limits that require a registered strength.

Special Groups Pregnancy:

Unsafe
Not applicable — the molecule is approved only in men for this indication.

Special Groups Breastfeeding:

Unsafe
Not applicable to the approved indications.

Special Groups Elderly:

Unsafe
Older men take more interacting medicines, and a product whose manufacturer cannot be identified offers no route to resolve a problem if one arises.

Special Groups Children:

Unsafe
No approved paediatric use exists for tadalafil in this indication.

Effects on Activities Driving:

Unsafe
Dizziness rises with dose and the dose is not established. Sudden vision changes mean stopping and seeking care.

Effects on Activities Operating Machinery:

Unsafe
The same applies, for the same reason.

No FDA record of any kind exists for this name, and the company most often named as its manufacturer was merged out of existence in 2003.31

The concern is that the chain of accountability has no first link. Every safety mechanism in medicine assumes a manufacturer exists and can be identified: recalls are issued by someone, inspections are of someone’s premises, and a report of harm is only actionable if it can be attached to a maker and a batch.

Here the answer to the first question varies by which vendor page you read. One names a company dissolved two decades ago, another its acquirer, another a competitor entirely. A user cannot verify a claim about a product when the sellers cannot agree who produced it.

One further observation belongs on a page about medical information rather than about a tablet. At least one vendor page carrying a named doctor as medical reviewer lists this product’s active ingredient as a run-together string of six unrelated brand names. A review byline attached to machine-generated text is worth recognising for what it is, because it is the signal most likely to persuade a reader that a page has been checked.2

Critical Warnings for Tadora Use

The named manufacturer no longer exists

German Remedies Ltd was acquired by Zydus Cadila in 2001 and merged into Cadila Healthcare in 2003. It survives as a trademark, not as a company that can answer questions about a batch.

Vendors disagree about who makes it

Listings variously name German Remedies, Zydus Cadila and Ajanta Pharma — the last an unrelated company with competing brands of its own.

A 40 mg strength appears in listings

Approved tadalafil for erectile dysfunction stops at 20 mg. The 40 mg dose is licensed for pulmonary arterial hypertension under separate brands and specialist supervision.

Nitrates

Tadalafil is contraindicated with any form of organic nitrate.4

Tadalafil hypersensitivity

Contraindicated after a serious hypersensitivity reaction to tadalafil (Cialis or Adcirca).4

Guanylate cyclase stimulators

Contraindicated with guanylate cyclase stimulators such as riociguat.4

See Interactions.

Dosage

No registered strength exists to check against
Listings describe 10, 20 and 40 mg tablets. Approved tadalafil for erectile dysfunction runs 2.5 to 20 mg; the 40 mg figure belongs to pulmonary arterial hypertension under separate brands.245
What Would Normally Establish a
MechanismAvailable here?
Published labelling from the manufacturerNo — the named manufacturer no longer exists
Registration with a national regulatorNo entry in any FDA source
A product code that resolves in a public directoryNone
Consistent vendor descriptionsNo — they disagree on maker and pack size

Source: 32

▶Clinical detailstechnical detail

Pharmacovigilance is built on being able to name a product and its maker. A report of harm is only useful if it can be attached to a manufacturer, a batch and a date, because those are what allow a pattern across several reports to be recognised and acted on.

A brand whose manufacturer is variously given as a dissolved company, its acquirer, or an unrelated competitor cannot support that chain at any point. Reports about it would attach to different entities depending on which listing the reporter happened to read, so even diligent reporting would scatter rather than accumulate. This is a different failure from simply having no data: the information exists but cannot be assembled.

Kidney and Liver Limits
FormulationActive IngredientsClinical Note
Renal impairmentTadalafilApproved labelling lowers or caps doses
Hepatic impairmentTadalafilApproved labelling caps doses in mild or moderate impairment and advises against use in severe impairment

Source: 4

What Does Tadora Interact With?

These are the labelled interactions of tadalafil.

Interactions by Severity
Interacting SubstanceEffect and RiskSeverityDocumentation
Organic nitrates in any form, including nitroglycerinDangerous fall in blood pressureContraindicatedExcellent — labelled contraindication
Guanylate cyclase stimulators such as riociguatLow blood pressureContraindicatedExcellent — labelled contraindication
Strong CYP3A4 inhibitors such as ketoconazole, ritonavirHigher exposure; as needed no more than 10 mg every 72 hoursMajorExcellent — labelled interaction
Alpha-blockers, other blood pressure medicines, alcoholAdditive fall in blood pressureModerateGood — labelled interaction
CYP3A4 inducers such as rifampinLower tadalafil exposureMinorGood — labelled interaction

Source: 4

It cannot be established. Listings name German Remedies Private Ltd, Zydus Cadila, or Ajanta Pharma — three different answers, one of them an unrelated competitor.
Zydus Cadila acquired it in 2001 and merged it into Cadila Healthcare in 2003 under a court-approved amalgamation. The name survives as a registered trademark and an internal business unit, not as a manufacturing company.
Every safety mechanism starts there. A named, existing manufacturer can be asked what is in a batch, can issue a recall and is subject to inspection. A retired trademark can do none of those things.
Not for erectile dysfunction, where approved tadalafil stops at 20 mg. The 40 mg dose is licensed for pulmonary arterial hypertension under separate brands and specialist supervision.
No. Reports attach to a named manufacturer and batch so that patterns can be recognised. Where vendors name three different makers, reports would scatter across entities rather than accumulate — the information would exist and still not assemble.

Evidence scope

What we know
  • German Remedies Ltd was acquired by Zydus Cadila in 2001 and merged into Cadila Healthcare in 2003 by court-approved amalgamation.
  • Vendor listings name three different manufacturers for this brand, one of them an unrelated competitor.
  • Strengths of 10, 20 and 40 mg appear in listings; pack descriptions vary between four and ten tablets per strip.
  • The brand returns nothing from any FDA system, which is the one thing about it that is not in dispute.
What remains uncertain
  • Who actually manufactures tablets sold under this name today.
  • What any individual tablet contains.
  • Whether the brand is still in production at all — several vendors list it as out of stock.

Source: 123

What has been reported to the FDA

Nothing under this name at the 30 July 2026 data cut.3

Why reports could not accumulate even if they were filed

An empty result records that nobody filed under this name, not that nothing happened.

Population note: this product has a reporting problem beyond the usual one. Pharmacovigilance works by attaching each report to a manufacturer, a batch and a date, so that several reports about the same product can be recognised as a pattern. Where vendors name three different companies as the maker, reports would attach to whichever was printed on the page the reporter happened to read. The information would exist and still not assemble — a different failure from having no data, and a harder one to detect.

Who was this medicine studied in?

No one. No product under this name has been submitted for approval anywhere, and no bioequivalence data exists for it.3

Who this is and is not appropriate for

No one, while three different companies are named as the maker and none can be held to anything. The contraindications of tadalafil apply to the molecule, and neither the maker nor the content of any tablet can be established.4

Approved generic tadalafil is registered at four strengths by many labelers, each identifiable and traceable.

Where to report and verify

Routing to Official Registries
What you needWhere to go
Report a side effectFDA MedWatch
Pregnancy-specific dataMotherToBaby
Full prescribing informationDailyMed
Verify a pharmacy websiteFDA BeSafeRx · LegitScript

References

  1. Cadila Healthcare / Zydus Lifesciences — corporate history and annual report disclosures
    Acquisition 2001; amalgamation completed 2003 by order of the Mumbai High Court · Accessed 2026-09-23
    Used for: the fate of German Remedies Ltd, the date of its merger into Cadila Healthcare, and its survival as a registered trademark rather than a manufacturing entity.
    zyduslife.com — Zydus Lifesciences
  2. Vendor and wholesale listings for Tadora
    Commercial listings, not regulatory records · Accessed 2026-09-23
    Used for: the three conflicting manufacturer attributions, the strengths offered and the differing pack descriptions, reproduced as claims.
  3. openFDA — labelling, Drugs@FDA, NDC Directory and FAERS queries for TADORA
    Data cut 2026-07-30 · Accessed 2026-09-23
    Used for: the absence of any application, product code, labelling or adverse event record under this brand name.
    open.fda.gov — drug adverse event API
  4. FDA Prescribing Information, CIALIS (tadalafil) — Sections 2, 4.1–4.3 and 7.2
    Revised 2026-06 · Accessed 2026-09-23
    Used for: the dosing limits, contraindications and interaction rules of the molecule, and which of them survive when the maker is unidentifiable.
    dailymed.nlm.nih.gov — CIALIS SPL
  5. Drugs@FDA — NDA 022332, ADCIRCA (tadalafil 40 mg)
    Records accessed 2026-09-23
    Used for: the approved status of the 40 mg dose for pulmonary arterial hypertension, cited because listings for this brand offer that strength for a different purpose.
    accessdata.fda.gov — Drugs@FDA

How this page was sourced

The corporate history is taken from company and court-approved filings rather than from any seller’s description, which is why this page can state it as fact while treating the manufacturer attributions on selling pages as competing claims.

The three attributions are reported together rather than resolved in favour of the commonest, because the disagreement itself is the finding.

Review cycle. Clinical review completed 28 September 2026. Next review due by 28 September 2027, or earlier if the labelling is revised.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.